1,890 Shares of Intuitive Surgical, Inc. $ISRG Acquired by NBT Bank N.A.

NBT Bank N.A. bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 1,890 shares of the medical equipment provider’s stock, valued at approximately $769,000.

A number of other large investors have also recently modified their holdings of ISRG. Main Street Group LTD purchased a new position in shares of Intuitive Surgical during the first quarter worth about $30,000. North Point Portfolio Managers Corp OH purchased a new stake in Intuitive Surgical in the third quarter valued at approximately $27,000. Evergreen Advisors LLC purchased a new stake in Intuitive Surgical in the first quarter valued at approximately $35,000. Compass Financial Management LLC bought a new stake in Intuitive Surgical during the second quarter valued at approximately $30,000. Finally, Pin Oak Investment Advisors Inc. bought a new stake in Intuitive Surgical during the second quarter valued at approximately $35,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical reported third-quarter revenue of approximately $3.05 billion, up more than 20% year over year, while earnings exceeded consensus expectations. The company also highlighted continued international expansion and adoption of its robotic-surgery systems. Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story
• Positive Sentiment: Several firms remain constructive: BTIG, Stifel Nicolaus, Piper Sandler, and Oppenheimer reaffirmed or maintained Buy ratings. Baird also raised its price target, while Erste Group upgraded the stock to Buy. ISRG was added to the Zacks Rank #1 Strong Buy list. New Strong Buy Stocks for October 23rd
• Neutral Sentiment: The quarter included roughly $450 million of costs tied to an antitrust settlement, along with pricing-related pressure, which reduced margins. These items appear largely nonrecurring, but investors are assessing their effect on near-term profitability. Intuitive Surgical Reports Q3 2026 Earnings Impacted by $450M Antitrust Settlement
• Negative Sentiment: The key concern is that U.S. da Vinci procedure growth slowed to its lowest level since the COVID period. Investors worry that decelerating domestic demand could make it harder for Intuitive Surgical to sustain its premium valuation, which remains above 50 times earnings. Intuitive Surgical Sinks as U.S. da Vinci Growth Slows
• Negative Sentiment: RBC lowered its expectations for ISRG, and an analyst downgrade contributed to a gap lower in the shares. The market is emphasizing forward growth and valuation rather than the headline earnings beat. Intuitive Surgical Shares Gap Down Following Analyst Downgrade

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of research reports. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Wednesday. TD Cowen restated a “buy” rating and set a $485.00 price objective on shares of Intuitive Surgical in a research report on Monday. UBS Group reaffirmed a “buy” rating on shares of Intuitive Surgical in a report on Tuesday, October 13th. Stifel Nicolaus cut their target price on shares of Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating for the company in a research report on Friday, July 17th. Finally, Evercore set a $430.00 target price on Intuitive Surgical in a research note on Monday, July 6th. One research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $493.54.

Intuitive Surgical Trading Up 1.9%

NASDAQ ISRG opened at $452.29 on Friday. The firm has a market cap of $156.78 billion, a PE ratio of 54.69, a price-to-earnings-growth ratio of 3.31 and a beta of 1.46. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88. The stock has a 50-day moving average of $395.50 and a 200-day moving average of $409.13.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. The company had revenue of $3.05 billion during the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The firm’s revenue was up 21.7% compared to the same quarter last year. During the same period in the prior year, the business posted $2.40 EPS. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

Insider Transactions at Intuitive Surgical

In related news, VP Fredrik Widman sold 1,089 shares of the firm’s stock in a transaction on Tuesday, September 15th. The stock was sold at an average price of $374.44, for a total value of $407,765.16. Following the completion of the sale, the vice president owned 1,026 shares of the company’s stock, valued at $384,175.44. This trade represents a 51.49% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 72 shares of Intuitive Surgical stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $393.10, for a total transaction of $28,303.20. Following the completion of the sale, the director owned 179 shares in the company, valued at approximately $70,364.90. This trade represents a 28.69% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 12,370 shares of company stock worth $4,891,989. Corporate insiders own 0.60% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.